Recall of Siemens Dimension Vista Hemoglobin A1c (HbA1c) Flex reagent cartridge

According to New Zealand Medicines and Medical Devices Safety Authority, this recall involved a device in New Zealand that was produced by Siemens Healthcare Diagnostics Inc.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    14469
  • Event Initiated Date
    2013-04-08
  • Event Country
  • Event Source
    NZMMDSA
  • Event Source URL
  • Notes / Alerts
    Data from New Zealand is current through July 2018. All of the data comes from the New Zealand Medicines and Medical Devices Safety Authority, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and New Zealand.
  • Extra notes in the data
    Recalling Organisation: Siemens Healthcare (NZ) Ltd, Millennium Centre, Part Level 2, Building A, 600 Great South Road, Ellerslie, AUCKLAND 1051
  • Reason
    There are two issues with hba1c:, (1) customers have been experiencing a higher frequency of “above assay range” flags on patient samples with the vista hba1c method., (2) some customers have experienced a high bias on patients' samples and us cap survey samples (2012 gh2-b) with the vista hba1c method.
  • Action
    Product to be destroyed

Device

  • Model / Serial
    Model: K3105A, Affected: Lots: 12072AA, 12150AA, 12248AA, 12086AA, 12191AA, 12261AA, 12107AA, 12212AA, 12282AA, 12128AA, 12226AA, 12303AA
  • Manufacturer

Manufacturer

  • Manufacturer Parent Company (2017)
  • Source
    NZMMDSA